Menu Search
Equities

EMIS Group PLC

483:BER

EMIS Group PLC

Actions
  • Price (EUR)12.28
  • Today's Change-0.28 / -2.23%
  • Shares traded0.00
  • 1 Year change-6.83%
  • Beta0.4563
Data delayed at least 15 minutes, as of Mar 05 2021 13:35 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

EMIS Group plc provides healthcare software, information technology and related services in the United Kingdom. The Company’s segments include Primary & Community Care and Community Pharmacy. The Company serves various healthcare markets under the EMIS Health brand. The Primary & Community Care division provides clinical information technology (IT) systems for general practitioners (GPs) and commissioners. The Community Pharmacy division is an integrated community pharmacy dispensary and retail system. EMIS Health provides clinical software to customers across the healthcare sector. Its brand EMIS Care specializes in the delivery of diabetic retinopathy eye screening.

  • Revenue in GBP (TTM)157.85m
  • Net income in GBP26.68m
  • Incorporated2008
  • Employees1.67k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		EMIS:LSE since
announced		Transaction
value
Pinnacle Health Partnership LLPDeal completed09 Mar 202009 Mar 2020Deal completed-5.84%9.13m
Pinnacle Systems Management LtdDeal completed09 Mar 202009 Mar 2020Deal completed-5.84%--
Data delayed at least 20 minutes, as of Mar 05 2021 14:04 GMT.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.